Innate Pharma
(OTC) IPHYF
Innate Pharma Financials at a Glance
Market Cap
$202.02M
Revenue (TTM)
$38.92M
Net Income (TTM)
$80.10M
EPS (TTM)
$-0.60
P/E Ratio
-3.61
Dividend
$0.00
Beta (Volatility)
-0.01 (Low)
Dividend
$0.00
Beta (Volatility)
-0.01 (Low)
Price
$2.15
Volume
15
Open
$2.15
Price
$2.15
Volume
15
Open
$2.15
Previous Close
$2.15
Daily Range
$2.15 - $2.15
52-Week Range
$1.31 - $2.90
Dividend
$0.00
Beta (Volatility)
-0.01 (Low)
Price
$2.15
Volume
15
Open
$2.15
Previous Close
$2.15
Daily Range
$2.15 - $2.15
52-Week Range
$1.31 - $2.90
IPHYF News
IPHYF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Innate Pharma
Industry
Biotechnology
Sector
Health CareEmployees
181
CEO
Jonathan Dickinson, MBA
Website
www.innate-pharma.comHeadquarters
Marseille, 13009, FR
IPHYF Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-271%
Return on Capital
-80%
Return on Assets
-50%
Earnings Yield
-27.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$202.02M
Shares Outstanding
93.74M
Volume
15
Short Interest
0.00%
Avg. Volume
1.066
Financials (TTM)
Gross Profit
$12.62M
Operating Income
$51.58M
EBITDA
$46.91M
Operating Cash Flow
$6.90M
Capital Expenditure
$391.00K
Free Cash Flow
$7.29M
Cash & ST Invst.
$80.77M
Total Debt
$31.00M
Innate Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.86M
-87.9%
Gross Profit
$15.66M
-279.1%
Gross Margin
-3.22%
N/A
Market Cap
$202.02M
N/A
Market Cap/Employee
$1.12M
N/A
Employees
181
N/A
Net Income
$21.34M
-1342.4%
EBITDA
$25.06M
-989.3%
Quarterly Fundamentals
Net Cash
$33.00M
-31.6%
Accounts Receivable
$363.00K
-99.3%
Inventory
$0.00
N/A
Long Term Debt
$18.09M
+3386.5%
Short Term Debt
$8.93M
N/A
Return on Assets
-49.55%
N/A
Return on Invested Capital
-79.81%
N/A
Free Cash Flow
$31.22M
-165.1%
Operating Cash Flow
$31.16M
-171.8%